ArticlePDF Available

Microcephaly at birth - the accuracy of three references for fetal head circumference. How can we improve prediction?

Authors:

Abstract and Figures

Objective: To evaluate the prediction of microcephaly at birth (micB) using established and two new reference ranges for fetal head circumference (HC) and to assess whether integrating additional parameters can improve prediction. Methods: Microcephaly in utero was defined as a fetal HC 3SD below the mean for gestational age according to Jeanty et al.'s reference range. The records of cases with fetal microcephaly (Fmic) were evaluated for medical history, imaging findings, biometry and postnatal examination/autopsy findings. Microcephaly was confirmed at birth (micB) by an occipitofrontal circumference (OFC) or a brain weight at autopsy 2SD below the mean for gestational age. The new INTERGROWTH-21(st) Project and a recent Israeli reference for fetal growth were applied for evaluation of the Fmic positive predictive value (PPV) for diagnosis of micB cases. Optimal HC cut-offs were determined for each of the new references with the aim of detecting all micB cases whilst minimizing the number of false positives found to have a normal HC at birth. We also assessed the difference between the Z-scores of the prenatal HC and the corresponding OFC at birth, the frequency of small-for-gestational age (SGA), decreased HC/abdominal circumference (AC) and HC/femur length (FL) ratios, the prevalence of associated malformations and family history. Results: Forty-two fetuses were diagnosed as having Fmic according to the Jeanty reference, but micB was confirmed in only 24 (PPV, 57.1%). The optimal INTERGROWTH and Israeli reference HC cut-offs for micB diagnosis were mean - 3SD and mean - 2.3SD, resulting in a statistically non-significant improvement in PPV to 61.5% and 66.7%, respectively. The presence of a family history of microcephaly, SGA, associated malformations and application of stricter HC cut-offs resulted in a higher PPV of micB, although not statistically significant and with a concurrent increase in the number of false-negative results. The deviation of the HC from the mean, by all references, was significantly larger compared with the actual deviation of the OFC at birth, with mean differences between the corresponding Z-scores of -1.15, -1.95 and -0.74 for the Jeanty, INTERGROWTH and Israeli references, respectively. Conclusions: The evaluated reference ranges all result in considerable over-diagnosis of fetal microcephaly. The use of the two new HC reference ranges did not significantly improve micB prediction compared with that of Jeanty et al., whilst use of additional characteristics and stricter HC cut-offs could improve the PPV with an increase in false negatives. The postnatal OFC deviates significantly less from the mean compared with the prenatal HC, and we propose that adjustment for this would enable better prediction of the actual OFC deviation at birth. Copyright © 2015 ISUOG. Published by John Wiley & Sons Ltd.
Content may be subject to copyright.
Accepted Article
Microcephaly at birth - the accuracy of three references for fetal head
circumference. How can we improve prediction?
Z. Leibovitz*, E. Daniel-Spiegel†, G. Malinger‡§, K. Haratz¶, M. Tamarkin¶, L.
Gindes¶, L. Ben-Sira**, D. Lev††, I. Shapiro*, H. Bakry*, B. Weizman*, A. Zreik*,
S. Egenburg‡‡, A. Arad‡‡, R. Tepper§§, D. Kidron¶¶, T. Lerman-Sagie¶
*Ultrasound unit, Department of Obstetrics and Gynecology, Bnai Zion Medical
Center, Haifa, Israel; †Department of Obstetrics and Gynecology, Haemek Medical
Center, Afula, Israel; ‡Lis Maternity Hospital, Division of OB-GYN Ultrasound, Tel-
Aviv Sourasky Medical Center, Tel Aviv, Israel; §Sackler Faculty of medicine, Tel-
Aviv University, Tel-Aviv, Israel; ¶Unit of Fetal Neurology and Prenatal Diagnosis,
Department of Obstetrics and Gynecology, Wolfson Medical Center, Holon, Israel;
**Department of Radiology, Tel Aviv Medical Center, Tel Aviv, Israel; ††Genetics
Institute, Edith Wolfson Medical Center, Holon, Israel; ‡‡Department of pathology,
Bnai Zion Medical Center, Haifa, Israel; §§Ultrasound unit, obstetrics and
gynecology, Meir Medical Center, Kfar-Saba, Israel; ¶¶ Department of pathology,
Meir Medical Center, Kfar Saba, Israel
Keywords: fetal microcephaly, prenatal diagnosis, head circumference
Corresponding author: Dr Z. Leibovitz, Ob/Gyn department, Bnai-Zion Medical
Center, P.O. Box 4940, Haifa 31048, Israel; (e-mail: zvi_l@yahoo.com,
zvi.leibovitz.dr@gmail.com)
This article has been accepted for publication and undergone full peer review but has not
been through the copyediting, typesetting, pagination and proofreading process, which
may lead to differences between this version and the Version of Record. Please cite this
article as doi: 10.1002/uog.15801
This article is protected by copyright. All rights reserved.
Accepted Article
Abstract
OBJECTIVE: To evaluate the ability to predict microcephaly at birth (MICB) by
using the conventional and two new prenatal references for fetal head circumference
(HC). To assess whether integrating additional parameters can improve prediction.
METHODS: Microcephaly in utero was defined as a fetal head circumference 3
standard deviations (SD) below the mean for gestational age according to Chervenak
et al's reference (CR). The records of cases with fetal microcephaly (FMIC) were
evaluated for the medical history, imaging findings, biometry, and postnatal
examination/autopsy findings. Microcephaly was confirmed at birth by an
occipitofrontal circumference (OFC) or a brain weight at autopsy 2SD below the
mean for gestational age. The new INTERGROWTH-21
st
Project (I21P)
and a recent
Israeli reference (IR) for fetal growth were applied for evaluation of the FMIC
positive predictive value (PPV) for diagnosis of cases with microcephaly at birth
(MICB). Optimal HC cut-offs were determined for each of the new references aimed
at detection of all MICB cases and minimizing the number of false positive ones
found with a normal head circumference at birth (NHCB). We assessed: the PPV of
the FMIC for MICB diagnosis, the difference between the z-scores of the prenatal HC
and the corresponding OFC at birth, the frequency of growth restriction, decreased
HC/abdominal circumference (AC) and HC/femur length (FL), the percentage of
associated malformations, and family history.
RESULTS: Forty two fetuses were diagnosed as having FMIC according to the CR.
In only 24 microcephaly was confirmed at birth or by autopsy (PPV 57.1%). The
optimal I21P and IR HC cut-offs for MICB diagnosis were the mean-3SD and the
mean-2.3SD, resulting in a statistically non-significant PPV improvement of 61.5%
and 66.7%, respectively. The presence of family history of MIC, IUGR, associated
malformations and application of stricter HC cut-offs resulted in a higher prediction
rate of MICB, although not statistically significant. The deviation of the HC from the
mean, by all references, was significantly larger compared to the actual deviation of
the OFC at birth. The mean differences between the corresponding z-scores of the HC
and OFC were -1.15, -1.95, and -0.74 for the CR, I21P, and IR, respectively. The
estimated weight of the cases with FMIC was below the 10
th
and 3
rd
percentile in
83.3% and 42.9%, correspondingly. A birth weight below the 3
rd
percentile was found
This article is protected by copyright. All rights reserved.
Accepted Article
in 34.8% of MICB and in 11.1% of NHCB (p<0.05). A low HC/AC and a low HC/FL
were found in 37.5% and 50% of MICB, and 27.8% and 55.6% NHCB cases,
respectively. Associated anomalies were found in 58.3% of MICB compared to 27.8%
of NHCB.
CONCLUSIONS: The evaluated references, all result in considerable over diagnosis
of fetal microcephaly. The use of the two new HC references did not significantly
improve MICB prediction compared to Chervenak et al's one. The OFC deviates
significantly less from the mean compared to the HC. By addition of a family history,
associated anomalies, IUGR, and stricter HC cut-offs we could improve the predictive
accuracy. We suggest that addition of the difference between the HC and OFC z-
scores, developed in this study, to a particular HC z-score will enable better
estimation of the actual OFC deviation at birth.
This article is protected by copyright. All rights reserved.
Accepted Article
Introduction
Microcephaly (MIC) is frequently associated with intellectual disability and
neurologic abnormalities. The definition of MIC after birth is non-uniform. Usually it
is defined as an occipitofrontal circumference (OFC) more than 2 standard deviations
(SD)
1
below the mean for age and gender, but some authors put the OFC cut-off at -
3SD
2
. Assuming a normal OFC distribution, 2.3% of children would be defined as
microcephalic based on an OFC of 2SD below the mean. However, published
estimates for this threshold at birth are lower (0.56%
3
and 0.54%
4
). For an OFC of
3SD below the mean only 0.1% of children would be diagnosed with MIC, which
corresponds to the published estimate of 0.14% of neonates
4
. The incidence of
intellectual disability correlates with the number of SDs the OFC deviates below the
mean: 11% and 51% for 2SD and 3SD, correspondingly
4
.
Similarly, the diagnosis of fetal microcephaly (FMIC) also relies on the measurement
of an abnormally small fetal head circumference (HC). There are many published
nomograms for fetal HC growth. Although new HC references have recently been
developed, the established ones are still commonly used, despite being based on
relatively small groups of fetuses and outdated measurement modalities
5,6
.
The yield of the commonly used growth charts for prenatal MIC diagnosis is
considered low. The inaccuracy is primarily related to the inconsistent HC
measurement methodology and the absence of properly designed studies aimed at
optimization of predictive strategies for prenatal diagnosis of MIC. Furthermore, the
sonographic HC z-score (expressed as a number of standard deviations below the
mean for gestational age) is consistently over-estimated relative to the corresponding
postnatal OFC z-score. In a study of fetuses with HC z-scores between -2 and -3, 90%
were found to be normocephalic at birth
7
.
In 1984 Jeanty et al developed HC growth standards based on a longitudinal
assessment of 45 normal pregnancies of medical personnel volunteers in New Haven,
Connecticut
5
. This reference was applied to fetuses with suspected microcephaly in
two studies by Chervenak et al
8,9
. The studies included a total of 40 fetuses. In only 13
MIC was confirmed at birth. Their established cut-off for FMIC diagnosis (HC z-
score -3SD) was associated with a PPV of 46%
8
and 50%
9
for a false negative rate
of zero and 15%, correspondingly. As a result of the low PPV numerous fetuses may
This article is protected by copyright. All rights reserved.
Accepted Article
be wrongly diagnosed as microcephalic; and in countries where termination of
pregnancy is an option, it may be inadequately offered.
Our study's main goals were to assess the accuracy of the established and new HC
nomograms in prediction of microcephaly at birth (MICB) and to assess whether
integrating additional parameters can improve prediction.
Materials and Methods
The records of cases with FMIC diagnosed between 2007 and 2014 were collected
from the registries of four Israeli medical centers. The inclusion criteria were:
available records of singleton pregnancies with a sonographically documented
gestational age in the first or early second trimester, a HC 3SD below the mean for
gestational age according to Chervenak et al's reference
8
(CR), OFC and weight at
birth or autopsy results.
Examinations were performed with Voluson E8, Voluson 730 Expert, and Voluson
730 Pro (GE Healthcare Ultrasound, Milwaukee, WI, USA) ultrasound machines. All
records were evaluated for the medical history, imaging results, laboratory data, and
postnatal examination or autopsy findings. Microcephaly was confirmed at birth by
an OFC 2SD below the mean
10
or a brain weight of less than 2SD on autopsy
11
.
The positive predictive values (PPV) of FMIC for diagnosis of microcephaly at birth
were calculated using CR and the two new fetal growth nomograms
12,13
.
The new nomograms differed in their methodology. The first, INTERGROWTH-21st
Project (I21P), was intended to produce prescriptive fetal growth standards in
singleton pregnancies by studying a worldwide cohort of young, educated, affluent,
adequately nourished, and clinically healthy women of low risk for adverse pregnancy
outcome
12
. The second one was a large Israeli population based reference (IR) of
singleton gestations that excluded cases of an uncertain gestational age, fetal
malformations, and known fetal syndromes
13
. This reference provided descriptive
growth standards without limitations of maternal age and health risk factors. In both
new references the HC was measured using an electronic ellipse facility outlining the
outer cranial borders, whereas Chervenak et al
8
calculated the HC by using the
biparietal diameter (BPD) as an outer-to-inner cranial measurement and the
This article is protected by copyright. All rights reserved.
Accepted Article
occipitofrontal diameter (OFD) as a distance between the middle of the bone echoes
applying a specific formula: HC=1.62(BPD+OFD)
5
(Figure 1).
To keep with the conventional MIC assessment, the z-score method was used for
evaluation of the fetal head size. Although originally based on the quantile regression
analysis, the IR was adjusted for HC z-score calculation (by developing of HC mean
and SD values according to gestational week). The developed table, formulas for the
HC and SD, and a HC z-score calculator are provided in the supplementary material.
Optimal HC cut-offs were determined for each HC reference aimed at detection of all
MICB cases and minimizing the number of false positive ones found with a normal
head circumference at birth (NHCB).
The categorical parameters for integration with HC cut-offs included: associated
IUGR (defined as an estimated fetal weight (EFW) below the 10
th
percentile), fetal
anomalies, and a family history of MIC.
The biometric parameters were: the EFW calculated according to Hadlock et al
14
(based on BPD, HC, abdominal circumference (AC), and femur length (FL)); fetal
and newborn weight percentiles according to Dolberg et al
15
; and HC/AC and HC/FL
according to Snijders et al
16
.
The accuracy of the HC and integrated criteria for diagnosis of microcephaly at birth
were assessed by the PPV and the false negative rate (FNR) for each of the studied
references. The PPV was calculated as a number of the MICB cases divided by a
number of the MICB and NHCB cases, all fulfilling a specified condition; and the
FNR as the number of MICB cases not fulfilling the specified condition divided by all
MICB cases. Statistical comparison between the PPV and FNR of the studied criteria
was performed by χ
2
test.
The HC z-scores according to the applied references were compared in each study
group (FMIC, MICB, and NHCB) by t-test for paired samples.
A comparison between the HC z-scores of the MICB and NHCB groups was
performed by t-test for unpaired samples.
This article is protected by copyright. All rights reserved.
Accepted Article
In each case the difference between the corresponding HC and OFC z-scores was
calculated according to the applied references and correlated to the time interval
between FMIC diagnosis and OFC assessment at birth.
The data was analyzed by IBM SPSS statistics software (IBM Corporation Software
Group, NY, US).
This study was approved by the Institutional Review Boards.
This article is protected by copyright. All rights reserved.
Accepted Article
Results
Using Chervenak et al's reference
8
a fetal head circumference 3SD below the mean
for gestational age was found in 42 fetuses (FMIC), of them at birth 24 were
diagnosed with microcephaly (MICB) and 18 had a normal HC (NHCB). The mean
gestational week at FMIC diagnosis was 32.6 ± 5.6 (range: 22 to 38). The mean
gestational week did not significantly differ between the MICB and the NHCB
subgroups (33.7 ± 5.3 and 31.0 ± 5.7, correspondingly). The female/male ratio of
FMIC was 1/1.14. A karyotype was obtained in 27 fetuses and was normal in all.
Serology for intrauterine infection was negative in all (including 2 cases of
histologically confirmed CMV fetopathy). Associated fetal anomalies were found in
45.2%, 58.3%, and 27.8% of FMIC, MICB, and NHCB cases, correspondingly.
The definite or possible etiology for microcephaly was determined in 23 of 24 MICB
cases: primary MIC (3), malformation of cortical development (4), pontocerebellar
hypoplasia (2), vermian hypoplasia (1), CMV fetopathy (2), hypoxic/hemorrhagic
brain damage (2), fetal alcohol syndrome (1), placental pathology (4), syndromic MIC
(3), and Aicardi-Goutières syndrome (1).
The etiology for small HC was established in 16 of 18 NHCB cases: Chiari-II
malformation with open spina bifida (4), vertical cranial elongation (5, coronal
craniosynostosis (1) and skull molding (4)), and placental pathology (2).
Microcephaly at birth was confirmed in only 24 fetuses according to Chervenak et al
8
(HC below mean-3SD) resulting in PPV of 57.1%. The optimal HC cut-offs for I21P
and IR were: mean-3SD and mean-2.3SD, correspondingly. These cut-offs resulted in
a PPV of 61.5% and 66.7%, respectively. Application of the 1
st
quantile cut-off of the
IR (the lowest reported quantile in the original paper
13
) provided a PPV of 65.7% with
a FNR of 4.2%. The PPV of the optimal HC cut-offs did not differ significantly
between the references (χ
2
test).
Table 1 summarizes the accuracy of the applied references for MICB diagnosis using
stricter and optimal HC cut-offs with integration of additional parameters (IUGR,
fetal malformations, and family history). Both, CR and IR achieved a PPV of 100%
for MICB at a HC < mean-4SD, whereas I21P did not exceed the PPV of 66.7% even
at a HC< mean-6SD. Integration of the optimal HC cut-offs with the presence of
IUGR, fetal anomalies, or family history had an additive effect on MICB prediction
This article is protected by copyright. All rights reserved.
Accepted Article
for all three references. Adding IUGR resulted in a PPV of 62.9%, 66.7%, and 73.3%
for EFW below the 10
th
percentile and 66.7%, 70.6%, and 75% below the 3
rd
percentile for the CR, I21P, and IR, respectively. Integration of the optimal HC cut-
offs with the presence of fetal anomalies resulted in a MICB PPV of 70%, 73.7%, and
82.4% for CR, I21P, and IR, correspondingly. Addition of a family history of MIC
resulted in a PPV of 100% for each reference. A comparison between the PPVs of the
above mentioned criteria did not reach statistical significance for each of the
references (explained by the small size of the groups). Similarly, the PPVs did not
differ significantly between the references, tested for the corresponding criteria (χ
2
test). As a rule, stricter HC cut-offs and integrated conditions were associated with a
high FNR of MICB for all references, reaching a maximum of 87.5% for the optimal
HC cut-off integrated with family history of MIC (p<0.0001, compared to a FNR of
an optimal HC cut-off alone; χ
2
test).
The mean HC z-scores in FMIC, MICB, and NHCB groups are presented in Table 2.
The I21P reference showed significantly lower HC z-scores compared to the other
two references, tested in each of the study groups (p<0.0001, t-test for paired
samples).
When the HC z-scores of the MICB fetuses were evaluated by CR and IR, they were
significantly lower compared to the NHCB's ones (p<0.04 and p<0.02 for CR and IR,
correspondingly; t-test for unpaired samples).
The HC z-scores of FMIC, MICB, and NHCB groups were significantly lower
(p<0.005, paired t-test) than the corresponding OFC ones for all prenatal references,
except for the MICB group according to IR (Table 3). The mean differences between
the HC and OFC z-scores of FMIC fetuses were: -1.15 (95% CI: -1.51 to -0.79), -1.95
(95% CI: -2.47 to -1.44), and -0.74 (95% CI: -1.07 to -0.40) for CR, I21P, and IR,
respectively.
The time interval between FMIC diagnosis and OFC assessment at birth was 2.4±4.1
weeks ranging between 1day and 17.6 weeks. No significant correlation was found
between the difference of the corresponding HC and OFC z-scores and the time
interval between the two assessments (Pearson's correlation coefficients were -0.05, -
0.3, and -0.15 for CR, I21P, and IR, respectively).
This article is protected by copyright. All rights reserved.
Accepted Article
The EFW of the FMIC cases was below the 10
th
and 3
rd
percentile in 83.3% and
42.9%, respectively. A birth weight below the 10
th
percentile was found in 78.3% and
33.3% of MICB and NHCB cases, and below the 3
rd
percentile in 34.8% and 11.1%,
correspondingly. A low birth weight was significantly more frequent in MICB cases
compared to NHCB (p<0.05).
A HC/AC <5
th
percentile was found in 33.3%, 37.5%, and 27.8% of FMIC, MICB,
and NHCB cases; and a HC/FL <5
th
percentile in 52.4%, 50%, and 55.6%,
respectively.
Termination of pregnancy was performed in 20 FMIC cases upon parental request
(47.6%): 11 and 9 fetuses of the MICB and NHCB groups, correspondingly.
Abnormal CNS finding on autopsy were found in 63.6% of MICB and in 33.3% of
NHCB (all with Chiari-II malformation). Six autopsies of fetuses from the NHCB
group were anatomically normal.
Neurological abnormalities were reported in 84.6% and 11.1% (p=0.01) of MICB and
NHCB live births, correspondingly. Death during the first 7 years occurred in 53.8%,
and 0% of MICB, and NHCB cases, respectively. Eight of the 9 patients from the
NHCB group had normal development.
This article is protected by copyright. All rights reserved.
Accepted Article
Discussion
In a recent update on a classification of malformations of cortical development by
Barkovich et al
17
, microcephaly is categorized according to the onset of the disorder
relative to the glial and neuronal migration phase. The premigrational category
includes multiple genetic disorders that manifest by fetal and neonatal microcephaly
due to reduced proliferation or excessive apoptosis of neuronal and glial cells. The
post-migrational category is related to decreased brain growth during late gestation or
the early postnatal period as a result of ischemia, infection, trauma, inborn metabolic
disorders, teratogens, and genetic factors. The last category develops in the first two
years of life, however, prenatal diagnosis may be possible, if the deceleration in head
growth is progressive and occurs relatively early in the third trimester. Patients with
isolated genetic MIC (primary MIC) are almost always born with a significantly small
OFC, but are not necessarily considered microcephalic at birth. Syndromic MIC
(associated with dysmorphism and/or brain and/or systemic malformations) is usually
diagnosed postnatally
18
.
FMIC, defined as a HC 3SD below the mean
8
, can be expected in 0.1% of
pregnancies, if the HC is normally distributed. However, the actual estimate of such
low HC measurements is probably higher. According to the Israeli registry
13
of the
11169 singleton pregnancies with certain dating and no fetal anatomical
malformations or known syndromes, 23 (0.2%) were found to have FMIC, while only
13 of them were diagnosed as microcephalic postnatally, resulting in a population
estimate of a false positive rate of 0.1%.
The correct prediction of MICB based on prenatal biometry is suboptimal
19
. In our
series, the established reference
8
resulted in over-diagnosis of FMIC in 43% of cases,
leading to erroneous termination of 6 pregnancies with apparently normal fetuses.
The use of the two new HC references
12,13
did not significantly improve MICB
prediction compared to Chervenak et al's one
8
(explained by a relatively small series).
The low predictive accuracy can also be related to the nomogram's statistical
properties: a mean HC that is too high for the actual population or a SD value that is
too small, may cause substantial changes in the z-score calculation. Figure 2
demonstrates that the mean HC growth curves, before 32-33 gestational weeks, are
very similar for all three references, whereas the nomogram used in CR
5
shows a
This article is protected by copyright. All rights reserved.
Accepted Article
progressive HC increment in later gestational weeks, relative to the I21P and IR.
Since 60% of our FMIC cases were diagnosed after 33 weeks, it can partially explain
the higher percentage of false positive cases according to CR.
The I21P data showed significantly lower HC z-scores compared to the other
references (Table 2) resulted by the low SD values of the I21P nomogram (Figure 2).
The extremely deviated HC z-scores were found in 6 NHCB cases (-3.9 to -6.6) and
in 4 MICB ones (-4.3 to -6.4), thus explaining why the I21P nomogram did not
exceed a PPV of 66.7% even with very strict HC cut-offs (Table 1).
A PPV of 100% was achieved for the HC cut-off below mean-4SD using both the CR
and IR nomograms. Adding a family history of MIC to the optimal HC cut-offs also
resulted in a PPV of 100% using all three references. Integrating either the presence
of IUGR or the association of fetal anomalies with the optimal HC cut-off by the IR
gave a maximal PPV of 75% and 82.4%, correspondingly (Table 1). Our series is
relatively small due to the rarity of a measurement of a HC< mean-3SD. Therefore,
the additive prediction of the stricter HC cut-offs and the integration of additional
parameters did not reach statistical significance. However, we suggest that
considering these parameters in every case of FMIC can improve the accuracy of
MICB prediction, although this improvement is associated with significantly high
false negative rates using all studied references (Table 1). This indicates that in many
FMIC cases the absence of integrated parameters will preclude accurate diagnosis of
MICB.
The difference between intrauterine and postnatal measurements of head size prevents
accurate MICB prediction (Figure 1). Sonographic HC measurements are consistently
underestimated relative to postnatal OFC and the difference increased with gestational
age
20
. The probable cause for the discrepancy is that the HC is measured as the
perimeter of the fetal skull while the OFC includes the scalp and hair. However,
differences in the anatomical landmarks for the HC and OFC assessment, molding,
scalp edema, interobserver and intraobserver variability of the HC measurements
21
may also affect the magnitude of the inconsistency. Our study demonstrates that in
addition to the multifactorial discrepancy between the HC and OFC measurements,
the deviation of the HC from the mean was significantly larger compared to the actual
deviation of the OFC at birth for all references (Table 3).
This article is protected by copyright. All rights reserved.
Accepted Article
No information exists on the correlation between the severity of FMIC and the risk for
intellectual disability; the only established risks are based on the degree of the
postnatal OFC deviation
4,22
. Therefore, only achievement of accurate prediction of the
OFC z-score at birth will enable precise prenatal prognostication. Based on
calculations in our study group we can provide confidence interval limits of the
difference between the HC and OFC z-scores (Table 3). These limits can be added to
a particular HC z-score in order to predict the range of the OFC one. The accuracy of
this new approach should be confirmed in future studies.
FMIC frequently presents with IUGR. In a study on congenital microcephaly detected
by prenatal ultrasound, 66% of the MICB cases were small for gestational age
23
.
IUGR is described in multiple disorders of both pre- and postmigrational
microcephaly
17,21,24
. FMIC in such cases can be misinterpreted as part of general fetal
growth restriction without taking into account a small head as an alarming prognostic
factor. Our study also confirms that MICB is strongly associated with IUGR,
indicating that restricted fetal growth cannot be considered as a "simple" explanation
for a small HC. According to our and den Hollander et al's results
23
a normal HC/AC
is found in the majority of FMIC cases, thus indicating that a disproportionately small
HC is not a typical feature of fetal microcephaly.
Recently a novel statistical approach allowing accurate individualized prediction of
late fetal and neonatal growth outcomes was proposed by Deter et al
25,26
. This method
is based on serial sonographic assessments of multiple biometric parameters (starting
from 18 gestational weeks and continuing all through pregnancy at 3-4 week
intervals). Unfortunately such a systematic follow-up is not always available in FMIC
cases which are usually first diagnosed in the third trimester. Moreover, the accuracy
of this approach for prediction of MICB needs to be assessed.
Placental pathology was an infrequent explanation for the association of MICB and
IUGR in our study (16.7%, 4/24). In contrast, Dahlgren et al
27
found that 79% of
microcephalic newborns had abnormal placental findings. However, it is not clear if
this was the sole pathology or part of a more complex disorder.
Our study showed no significant improvement in predicting MICB by application of
the new HC references compared to the established one. By addition of a family
history, associated anomalies, IUGR, and stricter HC cut-offs we could improve the
This article is protected by copyright. All rights reserved.
Accepted Article
predictive accuracy, however this improvement was not statistically significant due to
the small study groups. It is important to realize that in many MIC cases there are no
additional parameters to consider and therefore the ability to accurately predict
postnatal microcephaly remains limited. We found significantly better OFC z-scores
compared to the corresponding HC ones. We suggest that addition of the confidence
interval limits of the difference between the HC and OFC z-scores to a particular HC
z-score will enable an improved estimation of the actual OFC z-score at birth and
more precise counseling in cases with FMIC.
This article is protected by copyright. All rights reserved.
Accepted Article
Study limitations:
Our study was designed to predict a pathologically small OFC at birth without
considering the postnatal clinical outcome. The study was based on a relatively small
cohort. The correlation between the degree of fetal HC smallness and the incidence of
MIC during the postnatal years was not addressed. The correlation between the
severity of FMIC and intellectual disability was not studied.
This article is protected by copyright. All rights reserved.
Accepted Article
Table 1. Accuracy of fetal HC cut-offs and integrated parameters in predicting
microcephaly at birth according to the applied references
Predictive criterion
Positive predictive value
% (cases
#
)
False negative rate
% (cases
)
Chervenak et al
8
HCmean-3SD 57.1 (24/42) NA*
HCmean-3SD and EFW<10th% 62.9 (22/35) 8.3 (2/24)
HCmean-3SD and EFW<3rd% 66.7 (12/18) 50.0 (12/24)
HCmean-3SD and fetal anomalies 70.0 (14/20) 41.7 (10/24)
HCmean-3SD and familial MIC 100.0 (3/3) 87.5 (21/24)
HCmean-4SD 100.0 (8/8) 66.7 (16/24)
Papageorghiou et al
12
HCmean-3SD 61.5 (24/39) 0.0 (0/24)
HCmean-3SD and EFW<10th% 66.7 (22/33) 8.3 (2/24)
HCmean-3SD and EFW<3rd% 70.6 (12/17) 50.0 (12/24)
HCmean-3SD and fetal anomalies 73.7 (14/19) 41.7 (10/24)
HCmean-3SD and familial MIC 100.0 (3/3) 87.5 (21/24)
HCmean-4SD 65.4 (17/26) 29.2 (7/24)
HCmean-5SD 66.7 (8/12) 66.7 (16/24)
HCmean-6SD 66.7 (4/6) 83.3 (20/24)
Daniel-Spiegel et al
13
HCmean-2.3SD 66.7 (24/36) 0.0 (0/24)
HCmean-2.3SD and EFW<10th% 73.3 (22/30) 8.3 (2/24)
HCmean-2.3SD and EFW<3rd% 75.0 (12/16) 50.0 (12/24)
HCmean-2.3SD and fetal anomalies 82.4 (14/17) 41.7 (10/24)
HCmean-2.3SD and familial MIC 100.0 (3/3) 87.5 (21/24)
HC<1st quantile 65.7 (23/35) 4.2 (1/24)
HCmean-3SD 71.4 (15/21) 37.5 (9/24)
HCmean-4SD 100.0 (4/4) 83.3 (20/24)
HC - head circumference; SD - standard deviation; EFW - estimated fetal weight
* NA - not applicable (this cut-off was the inclusion criterion).
#
Numbers in parentheses indicate the MICB cases / (MICB+NHCB) cases, all
fulfilling the specified condition.
Numbers in parentheses indicate the MICB cases not fulfilling the specified
condition / all MICB cases.
This article is protected by copyright. All rights reserved.
Accepted Article
Table 2. HC z-scores in the study groups according to the applied references
HC - head circumference; SD - standard deviation;
FMIC - fetal microcephaly; MICB - microcephaly at birth; NHCB - normal head
circumference at birth.
The HC z-scores of each study group were compared according to the applied
references using the t-test for paired samples. The HC z-scores by the I21P were
significantly lower compared to ones by the CR and IR (p<0.0001
*
) in all study
groups. No statistically significant difference was found comparing the HC z-scores
according to the CR and IR in each of the groups.
The HC z-scores of the MICB and NHCB cases were compared by t-test for unpaired
samples using each reference. The MICB cases had significantly lower HC z-scores
compared to the NHCB's ones using CR and IR (p<0.04
and p<0.02
,
correspondingly), while the z-scores did not significantly differ for the I21P (p=0.3
).
Reference
HC z-score
FMIC (42 cases)
mean (SD)
HC z-score
MICB (24 cases)
mean (SD)
HC z-score
NHCB (18 cases)
mean (SD)
Chervenak et al
8
(CR) -3.56 (0.65) -3.74 (0.75)
-3.33 (0.37)
Papageorghiou et al
12
(I21P) -4.4 (1.12)
*
-4.56 (1.03)
*‡
-4.19 (1.24)
*‡
Daniel-Spiegel et al
13
(IR) -3.16 (0.9) -3.45 (0.97)
-2.78 (0.65)
This article is protected by copyright. All rights reserved.
Accepted Article
Table 3. Difference between the corresponding HC
*
and OFC
z-scores in the study
groups according to the applied references
HC - head circumference; OFC - occipitofrontal circumference; SD - standard
deviation; CI - confidence interval; FMIC - fetal microcephaly; MICB - microcephaly
at birth; NHCB - normal head circumference at birth.
*
Assessed at FMIC diagnosis
Assessed at birth
95% confidence intervals of the z-score differences are provided for the suggested
estimation of the actual OFC z-score at birth (see Discussion).
The differences between the corresponding HC and OFC z-scores were examined in
each study group comparing the z-scores according to the prenatal HC
nomograms
8,12,13
and the postnatal OFC reference
10
; (
#
p<0.005,
p=0.31; paired t-test).
Compared references
Z-score difference
FMIC (42 cases)
mean (SD)
Z-score difference
MICB (24 cases)
mean (SD)
Z-score difference
NHCB (18 cases)
mean (SD)
Chervenak et al
8
vs. Fenton et al
10
-1.15 (1.14)
#
(95% CI: -1.51 to -0.79)
-0.52 (1.0)
#
-1.95 (0.75)
#
Papageorghiou et al
12
vs. Fenton et al
10
-1.95 (1.62)
#
(95% CI: -2.47 to -1.44)
-1.24 (1.45)
#
-2.86 (1.37)
#
Daniel-Spiegel et al
13
vs. Fenton et al
10
-0.74 (1.06)
#
(95% CI: -1.07 to -0.40)
-0.18 (0.84)
-1.44 (0.88)
#
This article is protected by copyright. All rights reserved.
Accepted Article
References
1. Opitz JM, Holt MC. Microcephaly: general considerations and aids to
nosology. J Craniofac Genet Dev Biol. 1990;10(2):175-204.
2. Passemard S, Kaindl AM, Verloes A. Microcephaly. Handb Clin Neurol.
2013;111:129-41.
3. Vargas JE, Allred EN, Leviton A, Holmes LB. Congenital microcephaly:
phenotypic features in a consecutive sample of newborn infants. J Pediatr
2001;139:210-4.
4. Dolk H. The predictive value of microcephaly during the first year of life for
mental retardation at seven years. Dev Med Child Neurol 1991;33:974-83.
5. Jeanty P, Cousaert E, Hobbins JC, Tack B, Bracken M, Cantraine F. A
longitudinal study of fetal head biometry. Am J Perinatol. 1984;1:118-28.
6. Hadlock FP, Deter RL, Harrist RB, Park SK. Fetal head circumference:
relation to menstrual age. AJR Am J Roentgenol. 1982;138:649-53.
7. Stoler-Poria S, Lev D, Schweiger A, Lerman-Sagie T, Malinger G.
Developmental outcome of isolated fetal microcephaly. Ultrasound Obstet
Gynecol. 2010;36:154-8.
8. Chervenak FA, Jeanty P, Cantraine F, Chitkara U, Venus I, Berkowitz RL,
Hobbins JC. The diagnosis of fetal microcephaly. Am J Obstet Gynecol.
1984;149:512-7.
9. Chervenak FA, Rosenberg J, Brightman RC, Chitkara U, Jeanty P. A
prospective study of the accuracy of ultrasound in predicting fetal
microcephaly. Obstet Gynecol. 1987;69:908-10.
10. Fenton TR, Kim JH. A systematic review and meta-analysis to revise the
Fenton growth chart for preterm infants. BMC Pediatr. 2013;13:59.
11. Maroun LL, Graem N. Autopsy standards of body parameters and fresh organ
weights in nonmacerated and macerated human fetuses. Pediatr Dev Pathol.
2005;8:204-17.
12. Papageorghiou AT, Ohuma EO, Altman DG, Todros T, Cheikh Ismail L,
Lambert A, Jaffer YA, Bertino E, Gravett MG, Purwar M, Noble JA, Pang R,
Victora CG, Barros FC, Carvalho M, Salomon LJ, Bhutta ZA, Kennedy SH,
Villar J; International Fetal and Newborn Growth Consortium for the 21st
Century (INTERGROWTH-21st). International standards for fetal growth
This article is protected by copyright. All rights reserved.
Accepted Article
based on serial ultrasound measurements: the Fetal Growth Longitudinal
Study of the INTERGROWTH-21st Project. Lancet. 2014;384:869-79.
13. Daniel-Spiegel E, Weiner E, Yarom I, Doveh E, Friedman P, Cohen A, Shalev
E. Establishment of fetal biometric charts using quantile regression analysis. J
Ultrasound Med. 2013;32:23-33.
14. Hadlock FP, Harrist RB, Sharman RS, Deter RL, Park SK. Estimation of fetal
weight with the use of head, body, and femur measurements--a prospective
study. Am J Obstet Gynecol. 1985;151:333-7.
15. Dollberg S, Haklai Z, Mimouni FB, Gorfein I, Gordon ES. Birth weight
standards in the live-born population in Israel. Isr Med Assoc J. 2005;7:311-4.
16. Snijders RJ, Nicolaides KH. Fetal biometry at 14-40 weeks' gestation.
Ultrasound Obstet Gynecol. 1994;4:34-48.
17. Barkovich AJ, Guerrini R, Kuzniecky RI, Jackson GD, Dobyns WB. A
developmental and genetic classification for malformations of cortical
development: update 2012. Brain. 2012;135:1348-69.
18. Seltzer LE, Paciorkowski AR. Genetic disorders associated with postnatal
microcephaly. Am J Med Genet C Semin Med Genet. 2014;166:140-55.
19. Malinger G, Lev D, Lerman-Sagie T. Assessment of fetal intracranial
pathologies first demonstrated late in pregnancy: cell proliferation disorders.
Reprod Biol Endocrinol. 2003;1:110
20. Melamed N, Yogev Y, Danon D, Mashiach R, Meizner I, Ben-Haroush A.
Sonographic estimation of fetal head circumference: how accurate are we?
Ultrasound Obstet Gynecol. 2011;37:65-71.
21. Sarris I, Ioannou C, Chamberlain P, Ohuma E, Roseman F, Hoch L, Altman
DG, Papageorghiou AT; International Fetal and Newborn Growth Consortium
for the 21st Century (INTERGROWTH21st). Intra- and interobserver
variability in fetal ultrasound measurements. Ultrasound Obstet Gynecol.
2012;39:266-73.
22. Ashwal S, Michelson D, Plawner L, Dobyns WB; Quality Standards
Subcommittee of the American Academy of Neurology and the Practice
Committee of the Child Neurology Society. Practice parameter: Evaluation of
the child with microcephaly (an evidence-based review): report of the Quality
Standards Subcommittee of the American Academy of Neurology and the
This article is protected by copyright. All rights reserved.
Accepted Article
Practice Committee of the Child Neurology Society. Neurology. 2009;73:887-
97.
23. den Hollander NS, Wessels MW, Los FJ, Ursem NT, Niermeijer MF,
Wladimiroff JW. Congenital microcephaly detected by prenatal ultrasound:
genetic aspects and clinical significance. Ultrasound Obstet Gynecol.
2000;15:282-7.
24. Berkley E. and Abuhamad A.Sonographic dating and standard fetal biometry
(Chapter 8). In: Queenan JT, Spong CY, Lockwood CJ, eds. Queenan's
Management of High-Risk Pregnancy: An Evidence-Based Approach, 6th
Edition. Chichester, MO: Wiley-Blackwell; 2012:63-74.
25. Deter RL, Lee W, Sangi-Haghpeykar H, Tarca AL, Yeo L, Romero R.
Individualized fetal growth assessment: critical evaluation of key concepts in
the specification of third trimester size trajectories. J Matern Fetal Neonatal
Med. 2014;27:543-51
26. Deter RL, Lee W, Sangi-Haghpeykar H, Tarca AL, Yeo L, Romero R. Fetal
growth cessation in late pregnancy: its impact on predicted size parameters
used to classify small for gestational age neonates. J Matern Fetal Neonatal
Med. 2015;28:755-65
27. Dahlgren L, Wilson RD. Prenatally diagnosed microcephaly: a review of
etiologies. Fetal Diagn Ther. 2001;16:323-6
This article is protected by copyright. All rights reserved.
Accepted Article
Fig
u
cir
c
Le
g
Pa
n
ref
e
an
o
dist
by
a
Pa
n
out
e
ref
e
Pa
n
u
re 1. Asse
s
c
umference
g
end
n
el (a) dem
o
e
rence
8
(de
v
o
uter-to-in
n
ance betwe
a
formula:
H
n
el (b) sho
w
e
r cranial b
o
e
rences
12,13
.
n
el (c) illust
r
s
sment of f
e
(OFC)
o
nstrates th
e
v
eloped by
J
n
er cranial
m
en the mid
d
H
C=1.62(B
P
w
s HC meas
u
o
rders. Thi
s
r
ates the po
e
tal head ci
r
e
method o
f
J
eanty et al
5
m
easureme
n
d
le of the b
o
P
D+OFD).
u
rement us
i
s
method o
f
stnatal OF
C
r
cumferenc
f
HC assess
m
5
). The bip
a
n
t and the o
c
o
ne echoes.
i
ng an elect
r
f
HC assess
m
C
measure
m
e (HC) and
m
ent used i
n
a
rietal diam
e
c
cipitofron
t
The head
c
r
onic ellips
m
ent was a
p
m
ent includi
n
neonatal o
c
n
Cherven
a
e
ter (BPD)
t
al diamete
r
c
ircumferen
e
facility o
u
p
plied in b
o
n
g the scal
p
c
cipitofron
t
a
k et al's
is measure
d
r
(OFD) as
a
ce is calcul
u
tlining the
o
th new HC
p
and hair.
t
al
d
as
a
ated
This article is protected by copyright. All rights reserved.
Accepted Article
Fig
u
acc
o
Le
g
CR
,
HC
,
Th
e
ind
i
u
re 2. The
g
o
rding to t
h
g
end
,
Chervena
k
,
head circ
u
e
curves of
t
i
cated line
t
g
rowth cur
v
h
e applied r
e
k
et al
8
; I21
P
u
mference;
S
t
he HC and
ypes.
v
es of mean
e
ferences
P
, Papageo
r
S
D, standa
r
SD of eac
h
head circu
m
r
ghiou et al
1
r
d deviatio
n
h
reference
a
m
ference a
n
1
2
; Daniel-
S
n
.
a
re illustrat
e
n
d standard
S
piegel et a
l
e
d accordi
n
deviation
l
13
.
n
g to the
This article is protected by copyright. All rights reserved.
... This is accentuated by the absence of properly designed studies taking into consideration gender and ethnicity factors (Leibovitz and Lerman-Sagie, 2018). Methodological differences between prenatal and postnatal measurement of HC (discussed earlier in this paper), combined with different fetal HC measurement methods (calculated from biparietal diameter (BPD) and occipitofrontal diameter (OFD) as: HC = 1.62 × (BPD + OFD) or by measurement of an ellipse drawn around the outside of the calvarium) (Salomon et al., 2011), different refence charts, interobserver variability and differences in technical quality all contribute to diagnostic inaccuracies (Stoler-Poria et al., 2010;Leibovitz et al., 2016a). ...
... In a retrospective study on 42 fetuses (Leibovitz et al., 2016a) previously diagnosed in utero as microcephalic using Jeanty's reference range, with a 57% positive predictive value (PPV) in diagnosing microcephaly postnatally, (according to OFC measurement after birth or brain weight in autopsies after termination of pregnancy), two new references for fetal growth were used for evaluating the HC: the INTERGROWTH-21st project (Papageorghiou et al., 2014), and the new Israeli reference for fetal growth (Daniel-Spiegel et al., 2013). Both references were based on large populations and used modern measurement techniques (an electronic elliptical tool applied on the external skull border). ...
... Integrating other parameters like EFW <3rd% and fetal anomalies to the 3SD cutoff was found to increase the PPV from 57% (Leibovitz et al., 2016a) to 66 and 70%, respectively. Adding and family history to fetal HC 3SD below the mean for gestational age or setting the cutoff to 4SD below the mean, raised the PPV to 100% (Leibovitz and Lerman-Sagie, 2018). ...
Article
Full-text available
Microcephaly is a sign, not a diagnosis. Its incidence varies widely due to the differences in the definition and the population being studied. It is strongly related to neurodevelopmental disorders. Differences in definitions and measurement techniques between fetuses and newborns pose a great challenge for the diagnosis and prognostication of fetal microcephaly. A false positive diagnosis can result (in countries where it is legal) in erroneous termination of pregnancy, where a false negative diagnosis might lead to the birth of a microcephalic newborn. Microcephaly in growth restricted fetuses deserves special attention and separate evaluation as it is an important prognostic factor, and not necessarily part of the general growth retardation. Several genetic syndromes incorporating microcephaly and intrauterine growth retardation (IUGR) are discussed. Deceleration of the head circumference (HC) growth rate even when the HC is still within normal limits might be the only clue for developing microcephaly and should be considered during fetal head growth follow up. Combining additional parameters such as a positive family history, associated anomalies, and new measurement parameters can improve prediction in about 50% of cases, and thus should be part of the prenatal workup. Advances in imaging modalities and in prenatal genetic investigation along with the emergence of new growth charts can also improve diagnostic accuracy. In this article, we review the different definitions and etiologies of fetal microcephaly, discuss difficulties in diagnosis, investigate the reasons for the low yield of prenatal diagnosis, and provide improvement suggestions. Finally, we suggest an updated algorithm that will aid in the diagnosis and management of fetal microcephaly.
... Reports regarding the accuracy of prenatal fetal ultrasound measurements indicate that prenatal ultrasound is more accurate for excluding microcephaly than for detecting microcephaly [3]. The positive predictive value of prenatal ultrasound does not improve significantly even at 2.3 and 3.0 SD below the mean, leading to an overdiagnosis of fetal microcephaly [4]. The case presented in this report confirms previous studies' findings that fetal ultrasound alone has a limited ability to diagnose fetal microcephaly. ...
... Accurate screening for infectious diseases leads to a more accurate ultrasound diagnosis. The combination of a positive family history of fetal anomalies or microcephaly and ultrasound findings has been reported to increase the positive predictive value of prenatal ultrasound findings for microcephaly [4]; therefore, it is necessary to consider the risk of misdiagnosis when diagnosing microcephaly based on fetal ultrasound alone. ...
Article
A 25-year-old first-time mother from Nepal had a well-progressing spontaneous pregnancy. However, from the 37th week, her baby's biparietal diameter (BPD) stopped growing at around 83 mm. At 40 weeks, measurements suggested possible microcephaly and fetal growth failure but no other abnormalities. No travel, infections, or cytomegalovirus were identified prenatally. By 41 weeks, the BPD and head circumference (HC) decreased further, while the estimated fetal birth weight (EFBW) slightly increased. The baby girl was born at 41 weeks and 1 day with a low birth weight but a normal head circumference. Postnatal checks showed no abnormalities, and she was discharged with normal growth at 10 days old.
... 3D fetal brain MRI biometrics were performed in some studies (Fried et al., 2021), and the results showed no significant difference from 2D fetal brain MRI biometrics. However, the relationship of prenatal measurements and postpartum results needs further study (Leibovitz et al., 2016). The traditional 2D measurement range is easy to overdiagnose fetal microcephaly (Leibovitz & Lerman-Sagie, 2018). ...
Article
Full-text available
Purpose: To explore the application value of voxel-based morphometric (VBM) in prenatal diagnosis of microcephaly. Methods: A retrospective study of magnetic resonance imaging of fetuses with microcephaly was performed using a Single shot fast spin echo sequence. Semi-automatic segmentation of gray matter (GM), white matter (WM) and cerebrospinal fluid (CSF), calculation of their volumes and VBM analysis of their GM. Two independent samples t-test was used to statistically analyze the fetal GM volume in the microcephaly and normal control groups. Total intracranial volume (TIV), GM volume, WM volume and CSF volume were linearly regressed against gestational age and compared between the two groups. Results: In the fetus with microcephaly, GM volume of frontal lobe, temporal lobe, cuneus, anterior central gyrus and posterior central gyrus decreased significantly (P < 0.001, corrected by family wise error at mass level). The gray matter volume of microcephaly was significantly lower than that of the control group (except for 28 weeks of gestation)(P<0.05). TIV, GM volume, WM volume and CSF volume were all positively correlated with gestational age, and the curves in the microcephaly group were all lower than those in the control group. Conclusion: Compared with the normal control group, the GM volume of microcephaly fetuses decreased, and there were significant differences in many brain regions through VBM analysis.
... As previously discussed in a study by Leibovitz et al., the yield of the commonly used growth charts for prenatal diagnosis of microcephaly is low, and there is significant discrepancy between them. 22 Nevertheless, fetal deceleration of head circumference growth rate regardless of the reference range should be considered a 'red flag' and warrants further evaluation. 23 The scarcity of prenatal diagnosis of microcephaly in patients with CASK variants is difficult to understand even though around 50% are born with a head circumference below -2SD but can be due to development of microcephaly after the anatomic scan at 22 weeks and lack of measurements in the third trimester. ...
Article
Full-text available
Aim To assess whether microcephaly with pontine and cerebellar hypoplasia (MICPCH) could manifest in the prenatal period in patients with calcium/calmodulin‐dependent serine protein kinase (CASK) gene disorders. Method In this international multicentre retrospective study, we contacted a CASK parents' social media group and colleagues with expertise in cerebellar malformations and asked them to supply clinical and imaging information. Centiles and standard deviations (SD) were calculated according to age by nomograms. Results The study consisted of 49 patients (44 females and 5 males). Information regarding prenatal head circumference was available in 19 patients; 11 out of 19 had a fetal head circumference below –2SD (range −4.1SD to −2.02SD, mean gestational age at diagnosis 20 weeks). Progressive prenatal deceleration of head circumference growth rate was observed in 15 out of 19. At birth, 20 out of 42 had a head circumference below –2SD. A total of 6 out of 15 fetuses had a TCD z‐score below –2 (range −5.88 to −2.02). Interpretation This study expands the natural history of CASK‐related disorders to the prenatal period, showing evidence of progressive deceleration of head circumference growth rate, head circumference below –2SD, or small TCD. Most cases will not be diagnosed according to current recommendations for fetal central nervous system routine assessment. Consecutive measurements and genetic studies are advised in the presence of progressive deceleration of head circumference growth rates or small TCD. What this paper adds Progressive deceleration of fetal head circumference growth rate can be observed. A small transcerebellar diameter is an additional important manifestation. Most cases will not be diagnosed according to current recommendations for fetal central nervous system routine assessment. Consecutive measurements are advised when measurements are within the low range of norm.
... Therefore, the IG-21 project charts based on the idea that foetuses, infants, and children grow similarly all over the world under ideal nutritional, environmental, psychological living conditions have been widely discussed. A number of studies 32,37,[40][41][42][43][44][45][46] recently have compared their foetal and neonatal national growth references with the IG-21 study that was recently published, and obtained diverse results. Some studies did not find appreciable differences with IG-21 for newborn HC 40 or a statistically significant difference was observed only of female HC in the 97th percentile 32 . ...
Article
Full-text available
Neonatal head circumference (HC) not only represents the brain size of Homo sapiens, but is also an important health risk indicator. Addressing a lack of comparative studies on head size and its variability in term and preterm neonates from different populations, we aimed to examine neonatal HC by gestation according to a regional reference and a global standard. Retrospective analysis of data on neonatal HC obtained from the Lithuanian Medical Birth Register from 2001 to 2015 (423 999 newborns of 24–42 gestational weeks). The varying distribution by gestation and sex was estimated using GAMLSS, and the results were compared with the INTERGROWTH-21st standard. Mean HC increased with gestation in both sexes, while its fractional variability fell. The 3rd percentile matched that for INTERGROWTH-21st at all gestations, while the 50th and 97th percentiles were similar up to 27 weeks, but a full channel width higher than INTERGROWTH-21st at term. INTERGROWTH-21st facilitates the evaluation of neonatal HC in early gestations, while in later gestations, the specific features of neonatal HC of a particular population tend to be more precisely represented by regional references.
... The difference in methodology between prenatal and postnatal HC evaluation reduces the accuracy of fetal MIC diagnosis. The positive prediction of microcephaly at birth based on sonographic HC evaluation in utero ranges between 57% and 67% [99]. ...
Article
Full-text available
This paper describes the contemporary state of knowledge regarding processes that regulate normal development of the embryonic–fetal central nervous system (CNS). The processes are described according to the developmental timetable: dorsal induction, ventral induction, neurogenesis, neuronal migration, post-migration neuronal development, and cortical organization. We review the current literature on CNS malformations associated with these regulating processes. We specifically address neural tube defects, holoprosencephaly, malformations of cortical development (including microcephaly, megalencephaly, lissencephaly, cobblestone malformations, gray matter heterotopia, and polymicrogyria), disorders of the corpus callosum, and posterior fossa malformations. Fetal ventriculomegaly, which frequently accompanies these disorders, is also reviewed. Each malformation is described with reference to the etiology, genetic causes, prenatal sonographic imaging, associated anomalies, differential diagnosis, complimentary diagnostic studies, clinical interventions, neurodevelopmental outcome, and life quality.
Article
Aim This study aimed to clarify the factors influencing preeclampsia (PE) development in nulliparous Japanese women and to develop a PE prediction model using second trimester sonographic and clinical data readily available to obstetricians. Methods This historical cohort study examined the obstetric records of nulliparous women who delivered at Yamanashi Prefectural Central Hospital from January 2019 to May 2023. A model was constructed to predict the PE development rate, with a focus on 796 nulliparous women. The assessed outcome was PE, excluding superimposed PE. Data on maternal age, assisted reproductive technology, mean arterial pressure, uterine artery notching, and umbilical artery resistance index were extracted. Multivariable logistic regression analysis was conducted on these five factors. Results The incidence of PE was 4.3% (34/796). Multivariable analysis indicated significant odds ratios for the association of PE with mean arterial pressure (adjusted odds ratio: 1.06, 95% confidence interval: 1.03–1.10) and uterine artery notching (adjusted odds ratio: 6.28, 95% confidence interval: 2.82–14.0) in nulliparous women. The PE prediction formula was established as follows: Probability of PE development (%) = (odds/1 + odds) × 100, odds = e x and x = −11.3 + 0.039 × maternal age (years) + 0.91 × assisted reproductive technology + 0.061 × mean arterial pressure (mmHg) + 1.84 × uterine artery notching + 1.84 × umbilical artery resistance index. The sensitivity and specificity of this model were 58.8% and 84.5%, respectively (area under the curve: 0.79). Conclusions This study is the first to provide a prediction formula targeting the Japanese population. Our specialized model for nulliparous women could guide obstetricians to educate women regarding the precise prospect of PE development.
Article
Objectives: To evaluate which of 5 established norms should be used for sonographic assessment of fetal head circumference HC. Study design: Cross-sectional study using pooled data from 4 maternal-fetal medicine practices. Inclusion criteria were singleton fetus, gestational age 220/7 to 396/7 weeks, biometry measured, and fetal cardiac activity present. Five norms of HC were studied: Jeanty et al., Hadlock et al., the INTERGROWTH-21st Project (IG-21st), the World Health Organization Fetal Growth Curves (WHO), and the National Institutes of Child Health and Human Development Fetal Growth Studies unified standard (NICHD-U). The fit of our HC measurements to each norm was assessed by these criteria: mean z-score close to 0, standard deviation (SD) of z close to 1, low Kolmogorov-Smirnov D-statistic, high Youden J-statistic, close to 10% of exams >90th percentile, close to 10% of exams <10th percentile, and close to 2.28% of exams >2 SD below the mean. Results: In 23,565 ultrasound exams, our HC measurements had the best fit to the WHO standard (mean z-score 0.10, SD of z 1.01, D-statistic <0.01, J-statistic 0.83 to 0.94). The SD of the Jeanty reference was much larger than all the other norms and our measurements, resulting in under-diagnosis of abnormal HC. The means of the IG-21st and NICHD-U standards were smaller than the other norms and our measurements, resulting in under-diagnosis of small HC. The means of the Hadlock reference were larger than all the other norms and our measurements, resulting in over-diagnosis of small HC. Restricting the analysis to a low-risk subgroup of 4,423 exams without risk factors for large- or small-for-gestational age produced similar results. Conclusions: The WHO standard is likely best for diagnosis of abnormal HC. The Jeanty (Chervenak) reference suggested by the Society for Maternal-Fetal Medicine had poor sensitivity for microcephaly screening.
Article
We report a case of fetal microcephaly found during the second trimester ultrasound and confirmed by further ultrasound scans and fetal MRI. The array comparative genomic hybridisation analysis of the fetus and the male parent showed a 1.5 Mb deletion overlapping the Feingold syndrome region, an autosomal dominant syndrome that can cause microcephaly, facial/hand abnormalities, mild neurodevelopmental delay and others. This case illustrates the need for a detailed investigation by a multidisciplinary team to provide prenatal counselling regarding a postnatal outcome to the parents and orient their decision towards the continuation or termination of pregnancy.
Article
Full-text available
Background In 2006, WHO produced international growth standards for infants and children up to age 5 years on the basis of recommendations from a WHO expert committee. Using the same methods and conceptual approach, the Fetal Growth Longitudinal Study (FGLS), part of the INTERGROWTH-21st Project, aimed to develop international growth and size standards for fetuses. Methods The multicentre, population-based FGLS assessed fetal growth in geographically defined urban populations in eight countries, in which most of the health and nutritional needs of mothers were met and adequate antenatal care was provided. We used ultrasound to take fetal anthropometric measurements prospectively from 14 weeks and 0 days of gestation until birth in a cohort of women with adequate health and nutritional status who were at low risk of intrauterine growth restriction. All women had a reliable estimate of gestational age confirmed by ultrasound measurement of fetal crown–rump length in the first trimester. The five primary ultrasound measures of fetal growth—head circumference, biparietal diameter, occipitofrontal diameter, abdominal circumference, and femur length—were obtained every 5 weeks (within 1 week either side) from 14 weeks to 42 weeks of gestation. The best fitting curves for the five measures were selected using second-degree fractional polynomials and further modelled in a multilevel framework to account for the longitudinal design of the study. Findings We screened 13 108 women commencing antenatal care at less than 14 weeks and 0 days of gestation, of whom 4607 (35%) were eligible. 4321 (94%) eligible women had pregnancies without major complications and delivered live singletons without congenital malformations (the analysis population). We documented very low maternal and perinatal mortality and morbidity, confirming that the participants were at low risk of adverse outcomes. For each of the five fetal growth measures, the mean differences between the observed and smoothed centiles for the 3rd, 50th, and 97th centiles, respectively, were small: 2·25 mm (SD 3·0), 0·02 mm (3·0), and −2·69 mm (3·2) for head circumference; 0·83 mm (0·9), −0·05 mm (0·8), and −0·84 mm (1·0) for biparietal diameter; 0·63 mm (1·2), 0·04 mm (1·1), and −1·05 mm (1·3) for occipitofrontal diameter; 2·99 mm (3·1), 0·25 mm (3·2), and −4·22 mm (3·7) for abdominal circumference; and 0·62 mm (0·8), 0·03 mm (0·8), and −0·65 mm (0·8) for femur length. We calculated the 3rd, 5th 10th, 50th, 90th, 95th and 97th centile curves according to gestational age for these ultrasound measures, representing the international standards for fetal growth. Interpretation We recommend these international fetal growth standards for the clinical interpretation of routinely taken ultrasound measurements and for comparisons across populations. Funding Bill & Melinda Gates Foundation.
Article
Full-text available
Objective: To evaluate the impact of late 3rd trimester fetal growth cessation on anatomical birth characteristic predictions used in classifying SGA neonates. Methods: A prospective longitudinal study was performed in 119 pregnancies with normal neonatal growth outcomes. Seven biometric parameters were measured at 3-4 weeks intervals using 3D ultrasonography. Rossavik size models were determined to predict birth characteristics at different ages. Percent Differences (% Diff) were calculated from predicted and measured birth characteristics. Growth Cessation Ages (GCA) were identified when no systematic change in % Diff values occurred after specified prediction ages. Systematic and random prediction errors were compared using different assumptions about the GCA. Predicted and measured size parameters were used to determine six new Growth Potential Realization Index (GPRI) reference ranges. Five were used to sub-classify 34 SGA neonates (weight < 10th percentile) based on the number of abnormal GPRI values. Results: Growth cessation ages were 38 weeks for HC, AC, mid-thigh circumference, estimated weight and mid-arm circumference. Crown-heel length GCA was 38.5 weeks. At GCA, birth characteristics had prediction errors that varied from 0.08 ± 3.4% to 15.7 ± 9.1% and zero % Diff slopes after 38 weeks. Assuming growth to delivery gave increased systematic and random prediction errors as well as positive % Diff slopes after 38 weeks, MA. Seventeen of the SGA neonates had 0 or 1 abnormal GPRI values [Subgroup 1] and 17 others had 2 or more abnormal values [Subgroup 2]. In Subgroup 1, 4/85 (4.7%) of GPRI's were abnormal while in Subgroup 2, 43/85 (50.6%) were abnormal. Use of only one type of GPRI for SGA subclassification resulted in substantial false negative and some false positive rates when compared to subclassification based on all five GPRI values. Conclusions: Growth cessation occurred at approximately 38 weeks for all six birth characteristics studied. SGA neonates can be separated into normal and growth restricted subgroups based on the frequency of abnormal GPRI values (GPRI Profile Classification).
Article
Full-text available
Objectives: To characterize second and third trimester fetal growth using Individualized Growth Assessment methods in a larger cohort of fetuses with normal neonatal growth outcomes. Methods: A prospective longitudinal study of 119 pregnancies was performed from 18 weeks, MA, to delivery. Measurements of several 1D and 3D fetal size parameters were obtained from 3D volume data sets at 3-4 week intervals. Regression analyses were used to determine Start Points (SP) and Rossavik model (P = c {t} (k + st)) coefficients c. k and s for each parameter in each fetus. Second trimester growth velocity reference ranges were determined and size model specification functions re-established, the latter used to generate individual size models. Actual measurements were compared to predicted third trimester size trajectories using Percent Deviations. New age-specific reference ranges for the Percent Deviations of each parameter were defined using 2-level statistical modeling. Results: Rossavik models fit the data for all parameters very well (R(2): 99%), with SP's and k values similar to those found in much smaller cohorts. The c* values were strongly related to the second trimester slope (R(2): 97%), as was predicted s* to estimated c* (R(2): 54--95%). Rossavik models predicted third trimester growth with systematic errors close to 0%; random errors (95% range) ranged between 5.7 and 10.9% and 20.0 and 24.3% for 1D and 3D parameters, respectively. Conclusions: IGA procedures for evaluating second and third trimester growth are now established based on a larger cohort (4-6 fold larger). New, more rigorously defined, age-specific standards for the evaluation of third trimester size deviations are now available for nine anatomical parameters and a weight estimation procedure that incorporates a soft tissue parameter (fractional thigh volume). These results provide a means for more reliably assessing fetal growth on an individualized basis, thus minimizing the effect of biological differences in growth.
Article
Full-text available
Background The aim of this study was to revise the 2003 Fenton Preterm Growth Chart, specifically to: a) harmonize the preterm growth chart with the new World Health Organization (WHO) Growth Standard, b) smooth the data between the preterm and WHO estimates, informed by the Preterm Multicentre Growth (PreM Growth) study while maintaining data integrity from 22 to 36 and at 50 weeks, and to c) re-scale the chart x-axis to actual age (rather than completed weeks) to support growth monitoring. Methods Systematic review, meta-analysis, and growth chart development. We systematically searched published and unpublished literature to find population-based preterm size at birth measurement (weight, length, and/or head circumference) references, from developed countries with: Corrected gestational ages through infant assessment and/or statistical correction; Data percentiles as low as 24 weeks gestational age or lower; Sample with greater than 500 infants less than 30 weeks. Growth curves for males and females were produced using cubic splines to 50 weeks post menstrual age. LMS parameters (skew, median, and standard deviation) were calculated. Results Six large population-based surveys of size at preterm birth representing 3,986,456 births (34,639 births < 30 weeks) from countries Germany, United States, Italy, Australia, Scotland, and Canada were combined in meta-analyses. Smooth growth chart curves were developed, while ensuring close agreement with the data between 24 and 36 weeks and at 50 weeks. Conclusions The revised sex-specific actual-age growth charts are based on the recommended growth goal for preterm infants, the fetus, followed by the term infant. These preterm growth charts, with the disjunction between these datasets smoothing informed by the international PreM Growth study, may support an improved transition of preterm infant growth monitoring to the WHO growth charts.
Article
Accurate pregnancy dating is a critical component of prenatal management. Precise knowledge of gestational age is essential for the management of high-risk pregnancies and in particular fetal growth restriction. Although uterine size, as measured by the fundal height, provides a subjective assessment of the fetal size, ultrasound has a far more precise role in confirming gestational age.
Article
Several genetic disorders are characterized by normal head size at birth, followed by deceleration in head growth resulting in postnatal microcephaly. Among these are classic disorders such as Angelman syndrome and MECP2-related disorder (formerly Rett syndrome), as well as more recently described clinical entities associated with mutations in CASK, CDKL5, CREBBP, and EP300 (Rubinstein-Taybi syndrome), FOXG1, SLC9A6 (Christianson syndrome), and TCF4 (Pitt-Hopkins syndrome). These disorders can be identified clinically by phenotyping across multiple neurodevelopmental and neurobehavioral realms, and enough data are available to recognize these postnatal microcephaly disorders as separate diagnostic entities in their own right. A second diagnostic grouping, comprised of Warburg MICRO syndrome, Cockayne syndrome, and Cerebral-oculo-facial skeletal syndrome, share similar features of somatic growth failure, ophthalmologic, and dysmorphologic features. Many postnatal microcephaly syndromes are caused by mutations in genes important in the regulation of gene expression in the developing forebrain and hindbrain, although important synaptic structural genes also play a role. This is an emerging group of disorders with a fascinating combination of brain malformations, specific epilepsies, movement disorders, and other complex neurobehavioral abnormalities. © 2014 Wiley Periodicals, Inc.
Article
True microcephaly (head circumference ≤-3SD), either primary (present at birth) or secondary (of postnatal onset) results from an imbalance between progenitor cell production and cell death that lead to a reduced number of neuronal and glial cells within the brain, resulting in reduced brain growth. Primary non-syndromal microcephalies are recessive disorders resulting from abnormal control of mitotic spindle and cell cycle kinetics in progenitor cells. Microcephaly is also a frequent sign of defects in DNA double- and/or single-strand break repair and in nucleotide excision repair, in which it often is associated with general growth impairment. In these etiologies, cognitive functions are reasonably well preserved despite severe reduction in brain volume. Neuronal migration defects are often associated with secondary microcephaly, as are anomalies of telencephalic cleavage. Secondary microcephalies are often associated with increased neuronal death, and can be associated with metabolic disorders such as serine deficiency or thiamine pyrophosphate transporter deficiency. Microcephaly can be associated with hundreds of syndromal congenital anomalies, including many chromosomal disorders. Genetic etiologies of developmental microcephalies are reviewed.
Article
Objectives: Fetal growth evaluation is an essential component of pregnancy surveillance. There have been several methods used to construct growth charts. The conventional charts used in current daily practice are based on small numbers and traditional statistical methods. The purpose of this study was to improve fetal biometric charts based on a much larger number of observations with an alternative statistical method: quantile regression analysis. A comparison between the charts is presented. Methods: During the 12 years of study, 17,708 sonographic examinations of pregnant women from the north of Israel, between 12 and 42 weeks of pregnancy, were performed. Fetal measurements were obtained by several operators using various equipment and included head circumference, abdominal circumference, and femur length. Results: Growth charts were established based on these measurements. Conclusions: In this study, we constructed biometric growth charts using a large cohort of pregnant women. These charts offer the advantages of specific estimated regression parameters for each specified percentile, thus better defining the normal range. We suggest using these new charts in routine daily obstetric practice.
Article
To assess intra- and interobserver variability of fetal biometry measurements throughout pregnancy. A total of 175 scans (of 140 fetuses) were prospectively performed at 14-41 weeks of gestation ensuring an even distribution throughout gestation. From among three experienced sonographers, a pair of observers independently acquired a duplicate set of seven standard measurements for each fetus. Differences between and within observers were expressed in measurement units (mm), as a percentage of fetal dimensions and as gestational age-specific Z-scores. For all comparisons, Bland-Altman plots were used to quantify limits of agreement. When using measurement units (mm) to express differences, both intra- and interobserver variability increased with gestational age. However, when measurement of variability took into account the increasing fetal size and was expressed as a percentage or Z-score, it remained constant throughout gestation. When expressed as a percentage or Z-score, the 95% limits of agreement for intraobserver difference for head circumference (HC) were ± 3.0% or 0.67; they were ± 5.3% or 0.90 and ± 6.6% or 0.94 for abdominal circumference (AC) and femur length (FL), respectively. The corresponding values for interobserver differences were ± 4.9% or 0.99 for HC, ± 8.8% or 1.35 for AC and ± 11.1% or 1.43 for FL. Although intra- and interobserver variability increases with advancing gestation when expressed in millimeters, both are constant as a percentage of the fetal dimensions or when reported as a Z-score. Thus, measurement variability should be considered when interpreting fetal growth rates.